GTF2H4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.213600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.866600E-01
Normal-vs-Stage2
3.182000E-01
Normal-vs-Stage3
2.014400E-01
Normal-vs-Stage4
3.088400E-01
Stage1-vs-Stage2
6.442000E-01
Stage1-vs-Stage3
8.897600E-01
Stage1-vs-Stage4
6.728600E-01
Stage2-vs-Stage3
5.830600E-01
Stage2-vs-Stage4
7.258400E-01
Stage3-vs-Stage4
7.580200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.222800E-01
Normal-vs-AfricanAmerican
3.137000E-01
Normal-vs-Asian
3.638800E-01
Caucasian-vs-AfricanAmerican
8.519200E-01
Caucasian-vs-Asian
6.113400E-01
AfricanAmerican-vs-Asian
5.525400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.185200E-01
Normal-vs-Female
3.286000E-01
Male-vs-Female
7.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.263000E-01
Normal-vs-Age(41-60Yrs)
3.479000E-01
Normal-vs-Age(61-80Yrs)
2.952200E-01
Normal-vs-Age(81-100Yrs)
2.730200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.597400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.549000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.405900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.216820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.742200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.042300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.092800E-01
Normal-vs-Daily Drinker
1.538330E-02
Normal-vs-Weekly Drinker
3.859800E-01
Normal-vs-Occasional Drinker
2.237600E-01
Normal-vs-Social Drinker
2.943800E-01
Non Drinker-vs-Daily Drinker
4.118200E-01
Non Drinker-vs-Weekly Drinker
2.973400E-01
Non Drinker-vs-Occasional Drinker
3.341900E-02
Non Drinker-vs-Social Drinker
8.082800E-01
Daily Drinker-vs-Weekly Drinker
9.413900E-02
Daily Drinker-vs-Occasional Drinker
1.087610E-02
Daily Drinker-vs-Social Drinker
5.904000E-01
Weekly Drinker-vs-Occasional Drinker
2.811800E-01
Weekly Drinker-vs-Social Drinker
1.477800E-01
Occasional Drinker-vs-Social Drinker
2.987800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.740200E-01
Normal-vs-Grade 2
6.393000E-01
Normal-vs-Grade 3
1.723450E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.557700E-02
Grade 1-vs-Grade 3
9.136000E-02
Grade 1-vs-Grade 4
3.740200E-01
Grade 2-vs-Grade 3
5.670600E-01
Grade 2-vs-Grade 4
6.393000E-01
Grade 3-vs-Grade 4
1.723450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.994200E-01
Normal-vs-NonDiabetic
3.404000E-01
Diabetic-vs-NonDiabetic
2.742800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.550600E-01
Normal-vs-NoPancreatitis
3.223600E-01
Pancreatitis-vs-NoPancreatitis
6.671600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.225600E-01
Normal-vs-N1
3.170600E-01
N0-vs-N1
8.693400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.544800E-01
Normal-vs-TP53-NonMutant
3.144200E-01
TP53-Mutant-vs-TP53-NonMutant
4.157800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
